UPenn’s Bruce Levine discusses the progress of CAR-T at the 2023 CAR-TCR Summit
Dr. Levine talks about emerging technology trends that might improve CAR-T therapies on the six-year anniversary of the first approved CAR-T.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
​
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
​
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
​
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A